Search filters

List of works by Arnab Ghosh

Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity

scientific article published on 15 May 2013

B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity

scientific article published on 01 November 2011

CAR T cell therapy for multiple myeloma: where are we now and where are we headed?

scientific article published on 6 November 2017

Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.

scientific article published on 9 January 2017

Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.

scientific article published on 30 January 2009

Generation and characterization of a novel hematopoietic progenitor cell line with DC differentiation potential.

scientific article published on May 2006

Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers

scientific article published on January 2014

Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth

scientific article

Interleukin-22 drives endogenous thymic regeneration in mice

scientific article

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease

scientific article

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.

scientific article published on 9 November 2016

PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD

scientific article published on 03 June 2013

Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

scientific article

Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors

scientific article published in September 2017

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease

scientific article

Paulina is supported by:

About Paulina

Help